A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8773518

Hum. Gene Ther. 1996 Jun 10 7 9 1161-79

Download in:

View as

Triples

General Info

PMID
8773518